Logo
x

Search category

Subscribe Now

All Posts by Date

PharmaShots Weekly Snapshots (July 11 – 15, 2022)

PharmaShots Weekly Snapshots (July 11 – 15, 2022)

  • July 15, 2022
Polpharma Biologics Report EMA's Acceptance of MAA for Biosimilar Natalizumab, a Proposed Biosimilar to Tysabr for Relapsing-Remitting Multiple Sclerosis

Polpharma Biologics Report EMA's Acceptance of MAA for Biosimilar Natalizumab, a Proposed Biosimilar to Tysabr for Relapsing-Remit...

  • July 15, 2022
BMS' Opdivo (nivolumab) + Yervoy (ipilimumab) Receives NICE Recommendation as 1L Treatment of Malignant Pleural Mesothelioma

BMS' Opdivo (nivolumab) + Yervoy (ipilimumab) Receives NICE Recommendation as 1L Treatment of Malignant Pleural Mesothelioma

  • July 15, 2022
Grünenthal Entered into an Agreement with Bayer to Acquire Nebido for Male Hypogonadism Associated with Testosterone Deficiency

Grünenthal Entered into an Agreement with Bayer to Acquire Nebido for Male Hypogonadism Associated with Testosterone Deficiency

  • July 15, 2022
Royalty Pharma to Acquire Royalty Rights from Theravance and Innoviva for ~$1.5B

Royalty Pharma to Acquire Royalty Rights from Theravance and Innoviva for ~$1.5B

  • July 15, 2022
Genentech Presents Two-Year Data of Vabysmo in P-III (TENAYA) and (LUCERNE) Studies for Wet Age-Related Macular Degeneration at ASRS 2022

Genentech Presents Two-Year Data of Vabysmo in P-III (TENAYA) and (LUCERNE) Studies for Wet Age-Related Macular Degeneration at AS...

  • July 15, 2022
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.